We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Antigen Detection Test Guides Antibiotic Use

By LabMedica International staff writers
Posted on 18 Nov 2013
The effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests were compared with delayed antibiotic prescribing.

Sore throat is one of the respiratory infections for which there are several reasonable diagnostic strategies for targeting antibiotics and rapid streptococcal antigen detection tests (RADTs) are one of the commonest near patient tests in clinical use internationally. More...
Clinical scores are also used to predict streptococcal infection used either alone or in combination with the antigen test.

Scientists at the University of Southampton (UK) recruited 631 patients with an acute sore throat and compared use of the FeverPAIN clinical score, with or without rapid antigen testing, with a delayed prescription, in which patients were told to pick up a prescription three to five days later if their symptoms did not settle or got worse. The FeverPAIN score includes fever in the past 24 hours, a pus infection, rapid attendance within three days, inflamed tonsils and no cough or cold symptoms.

The IMI test pack RADT (Inverness Medical; Bedford, UK) was used to detect Lancefield Group A Streptococcus based on in vitro performance and ease of use. The results showed that using the FeverPAIN score reduced antibiotic use by almost 30% and despite using fewer antibiotics, patients in the FeverPAIN score group experienced a greater improvement in symptoms. One in three patients in the FeverPAIN score group said their sore throat had improved rapidly from a moderately bad problem to a slight problem within two to four days. Moderately bad or worse symptoms also got better faster in the clinical score group.

However, the use of an in-practice rapid antigen test in conjunction with the FeverPAIN score did not result in any further reductions in antibiotic use or improvements in symptoms. The use of a rapid antigen test as well as the FeverPAIN test for patients who displayed streptococci symptoms did not offer any further improvements, with a 27% reduction in antibiotic use as well as similar improvements in patients' symptoms.

Michael Moore, MRCP, FRCGP, a coauthor of the study, said, “Clinicians can consider using a clinical score to target antibiotic use for acute sore throat, which is likely to reduce antibiotic use and improve symptom control. There is no clear advantage in the additional use of a rapid antigen test.” The study was published on October 10, 2013, in the journal British Medical Journal.

Related Links:

University of Southampton
Inverness Medical 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.